Numerous approved monoclonal antibody-based biopharmaceutical products for a range of therapies are on the rise and are expected to expand quickly. This includes the recent development of sotrovimab ...

TimesMachine is an exclusive benefit for home delivery and digital subscribers. About the Archive This is a digitized version of an article from The Times’s print archive, before the start of online ...

As Raman technology has advanced more challenging applications have been explored, where high fluorescence and low concentration of samples are present. Monoclonal antibodies and antibody fragments ...